Recursion, targeting cancer, rare disease midstage tests, sets terms for $306M IPO
Recursion Pharmaceuticals has set terms for a major $306 million IPO as the artificial intelligence biotech eyes a $3 billion valuation.
Source: fiercebiotech.com
Page 4 - Recursion Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Recursion Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Recursion Pharma Today - Breaking & Trending Today